Overview

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors select the best treatment for patients and predict their response to treatment. PURPOSE: This randomized phase II/III trial is studying how well tumor tissue testing works in selecting treatment for patients with metastatic or locally advanced colorectal cancer.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Medical Research Council
Treatments:
Bevacizumab
Calcium
Cetuximab
Fluorouracil
Irinotecan
Leucovorin
Levoleucovorin
Oxaliplatin